[PDF] Myelodysplastic Syndromes Secondary Acute Myelogenous Leukemia - eBooks Review

Myelodysplastic Syndromes Secondary Acute Myelogenous Leukemia


Myelodysplastic Syndromes Secondary Acute Myelogenous Leukemia
DOWNLOAD

Download Myelodysplastic Syndromes Secondary Acute Myelogenous Leukemia PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Myelodysplastic Syndromes Secondary Acute Myelogenous Leukemia book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page



Myelodysplastic Syndromes Secondary Acute Myelogenous Leukemia


Myelodysplastic Syndromes Secondary Acute Myelogenous Leukemia
DOWNLOAD
Author : Azra Raza
language : en
Publisher: Springer Science & Business Media
Release Date : 2012-12-06

Myelodysplastic Syndromes Secondary Acute Myelogenous Leukemia written by Azra Raza and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-12-06 with Medical categories.


Myelodysplastic syndromes are to the bone marrow what pneumonia is to the lungs; the response of an organ to a variety of etiologic insults like aging, toxic exposure, infections and auto-immunity. Among infectious causes alone, pneumonia could be the result of a variety of possible pathogens including bacterial, viral, tuberculous or fungal agents. Similarly, MDS cannot be treated as a single disease. Attempts to harness the inherent complexity of MDS by devising `classifications' which group the various syndromes as one disease is as misguided as saying that a pneumonia is not infectious because it did not respond to antibiotics. Progress in the field will occur faster when we re-analyze this premise. Therefore, until a clearer picture of the disease emerges it is best to treat each of the MDS syndromes as a separate entity. Having no classification is better than a misleading one. Cancer research has been notable for its periodic cycles of promise and hope, followed by defeat and disappointments. It is not that there is no solution, but that the problem has not been identified precisely. This book is our attempt to define the most crucial questions related to MDS that need to be addressed immediately through logic, analysis and rigorous experimentation. If the emerging problems appear daunting, then instead of being overwhelmed by them, we should follow the advice of the great 20th century thinker Antonio Gramsci, `pessimism of the intellect must be faced with the optimism of will'.



Epidemiology Of Secondary Leukemia With Reference To Chromosomal Abnormalities


Epidemiology Of Secondary Leukemia With Reference To Chromosomal Abnormalities
DOWNLOAD
Author : Ashraful Hoque
language : en
Publisher:
Release Date : 1997

Epidemiology Of Secondary Leukemia With Reference To Chromosomal Abnormalities written by Ashraful Hoque and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1997 with Acute myeloid leukemia categories.


Secondary acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) have been recognized as one of the most feared long-term complications of cancer therapy. The aim of this case-control study was to determine the prevalence of chromosomal abnormalities and family history of cancer among secondary AML/MDS cases and de novo AML/MDS controls. Study population were 332 MD Anderson Cancer Center patients who were registered between 1986 and 1994. Cases were patients who had a prior invasive cancer before diagnoses of AML/MDS and controls were de novo AML/MDS. Cases (166) and controls (166) were frequency matched on age $\pm$5 years, sex and year of diagnosis of leukemia. Cytogenetic data were obtained from the leukemia clinic database of MD Anderson Cancer Center and data on family history of cancer and other risk factors were abstracted from the patients' medical record. The distribution of AML and MDS among cases was 58% and 42% respectively and among controls 67% and 33% respectively. Prevalence of chromosomal abnormalities were observed more frequently among cases than controls. Reporting of family history of cancer were similar among both groups. Univariate analysis revealed an odds ratio (OR) of 2.8 (95% CI 1.5-5.4) for deletion of chromosome 7, 1.9 (95% CI 0.9-3.8) for deletion of chromosome 5, 2.3 (95% CI 0.8-6.2) for deletion of 5q, 2.0 (95% CI 1.0-4.2) for trisomy 8, 1.3 (95% CI 0.8-2.1) for chromosomal abnormalities other than chromosome 5 or 7 and 1.3 (95% CI 0.8-2.0) for family history of cancer in a first degree relative. The OR remained significant for deletion of chromosome 7 (2.3, 95% CI 1.1-4.8) after adjustment for age, alcohol, smoking, occupation related to chemical exposure and family history of cancer in a first degree relative. Of the 166 secondary AML/MDS patients 70% had a prior solid tumor and 30% experienced hematological cancers. The most frequent cancers were breast (21.1%), non-Hodgkin lymphoma (13.3%), Hodgkin's disease (10.2%), prostate (7.2%), colon (6%), multiple myeloma (3.6%) and testes (3.0%). The majority of these cancer patients were treated with chemotherapy or radiotherapy or both. Abnormalities of chromosome 5 or 7 were found to be more frequent in secondary AML/MDS patients with prior hematological cancer than patients with prior solid tumors. Median time to develop secondary AML/MDS was 5 years. However, secondary AML/MDS among patients who received chemotherapy and had a family history of cancer in a first degree relative occurred earlier (median 2.25 $\pm$ 0.9 years) than among patients without such family history (median 5.50 $\pm$ 0.18 years) (p $



Myelodysplastic Syndromes


Myelodysplastic Syndromes
DOWNLOAD
Author : Franz Schmalzl
language : en
Publisher: Springer Science & Business Media
Release Date : 2012-12-06

Myelodysplastic Syndromes written by Franz Schmalzl and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-12-06 with Medical categories.


The myelodysplastic syndromes pose important clinical and scientific challenges which in recent years have attracted growing interest within haemato-oncology and molecular genetics. Their potential as a model for the study of human leukaemogenesis makes this one of the most exciting fields in contemporary haematology.



Myelodysplastic Syndromes An Issue Of Hematology Oncology Clinics Of North America


Myelodysplastic Syndromes An Issue Of Hematology Oncology Clinics Of North America
DOWNLOAD
Author : David Steensma
language : en
Publisher: Elsevier Health Sciences
Release Date : 2020-02-26

Myelodysplastic Syndromes An Issue Of Hematology Oncology Clinics Of North America written by David Steensma and has been published by Elsevier Health Sciences this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-02-26 with Medical categories.


This issue of Hematology/Oncology Clinics, guest edited by David P. Steensma, will cover key topics in Myelodysplastic Syndromes. This issue is one of six selected each year by our series consulting editors, George P. Canellos and Edward J. Benz. Topics discussed in this issue will include: Novel prognostic models for MDS, Evaluating MDS patients with genetic mutations that might be germline, Implications of splicing mutations in MDS for pathophysiology and therapy, Assessing quality of life in MDS/MPN overlap patients, Creation of a clinic for patients with clonal hematopoiesis, Luspatercept in MDS, Prospects for venetoclax in MDS, Treatment of acquired sideroblastic anemias, Treatment of patients with AML arising from MDS, Targeting TP53 mutations in MDS, among others.



New Findings On Aclarubicin In The Treatment Of Acute Myeloid Leukemia


New Findings On Aclarubicin In The Treatment Of Acute Myeloid Leukemia
DOWNLOAD
Author : W. Hiddemann
language : en
Publisher: Springer Science & Business Media
Release Date : 2012-12-06

New Findings On Aclarubicin In The Treatment Of Acute Myeloid Leukemia written by W. Hiddemann and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-12-06 with Medical categories.


Since the introduction of new anthracycline derivatives and anthrachi none analogues a few years ago, aclacinomycin A (Aclarubicin) has become an established agent for the treatment of hematologic malig nancies. A special symposium was therefore held during the congress of the German Society of Hermatology and Oncology in Hannover in October 1989 to provide an up-to-date overv.iew. Leading experts from the United States, Sweden, and Germany reported on the results being obtained with aclacinomycin A, alone or combined with other agents, in patients with acute leukemias and myelodysplastic syndromes. This book is based on their contributions. As regards single-agent treatment, aclacinomycin A in myelodys plastic syndromes is dealt with, as well as its application in older patients with acute myeloid leukemia. Four contributions are devoted to the use of aclacinomycin A in combination with conventional or intermediate dose cytosine arabinoside or etoposide in patients with relapsed or refractory acute myeloid leukemia. The results reported indicate that aclacinomycin A has substantial activity in the treatment of hematologic malignancies. In summary, this book provides a valuable update on the current status of aclacinomycin A as used by experts in the treatment of he matologic malignancies.



Intensive Treatment Strategies In Patients With High Risk Myelodysplastic Syndrome And Secondary Acute Myeloid Leukemia


Intensive Treatment Strategies In Patients With High Risk Myelodysplastic Syndrome And Secondary Acute Myeloid Leukemia
DOWNLOAD
Author : Margreet Oosterveld
language : en
Publisher:
Release Date : 2005

Intensive Treatment Strategies In Patients With High Risk Myelodysplastic Syndrome And Secondary Acute Myeloid Leukemia written by Margreet Oosterveld and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2005 with categories.




Myelodysplastic Syndromes


Myelodysplastic Syndromes
DOWNLOAD
Author : Peter L. Greenberg
language : en
Publisher: Cambridge University Press
Release Date : 2011-02-17

Myelodysplastic Syndromes written by Peter L. Greenberg and has been published by Cambridge University Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2011-02-17 with Medical categories.


Myelodysplastic Syndromes was first published in 2006, and continues to stand out as the definitive text on the genetics, pathophysiology, and clinical management of this wide range of syndromes. It remains a major reference on all aspects of the clinical classification underlying pathogenetic mechanisms and treatment of the myelodysplastic syndromes. Authored by international experts, the book provides an assessment of the subject's status and a variety of advances in the field. The chapters cover all aspects of the myelodysplastic syndromes, from an in-depth analysis of the multifactorial nature of this disease, including a careful assessment of stromal, immunological and stem cell abnormalities, to a review of recent molecular and cytogenetic discoveries and insights. This book will be a valuable resource to clinicians and researchers who wish to learn more about myelodysplastic syndromes.



The Ebmt Handbook


The Ebmt Handbook
DOWNLOAD
Author : Nicolaus Kröger
language : en
Publisher:
Release Date : 2020-10-08

The Ebmt Handbook written by Nicolaus Kröger and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-10-08 with Medical categories.


This Open Access edition of the European Society for Blood and Marrow Transplantation (EBMT) handbook addresses the latest developments and innovations in hematopoietic stem cell transplantation and cellular therapy. Consisting of 93 chapters, it has been written by 175 leading experts in the field. Discussing all types of stem cell and bone marrow transplantation, including haplo-identical stem cell and cord blood transplantation, it also covers the indications for transplantation, the management of early and late complications as well as the new and rapidly evolving field of cellular therapies. This book provides an unparalleled description of current practices to enhance readers' knowledge and practice skills. This work was published by Saint Philip Street Press pursuant to a Creative Commons license permitting commercial use. All rights not granted by the work's license are retained by the author or authors.



The Myelodysplastic Syndromes


The Myelodysplastic Syndromes
DOWNLOAD
Author : John Bennett
language : en
Publisher: CRC Press
Release Date : 2002-05-21

The Myelodysplastic Syndromes written by John Bennett and has been published by CRC Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2002-05-21 with Medical categories.


This reference provides a comprehensive overview of the latest research detailing the etiology, epidemiology, treatment, and detection of myelodysplastic syndromes (MDS)-identifying effective therapeutic regimens, adverse environmental and genetic factors, and efficient modalities of supportive care that improve patient survival and enhance quality



Acute Myelogenous Leukemia


Acute Myelogenous Leukemia
DOWNLOAD
Author : Judith E. Karp
language : en
Publisher: Springer Science & Business Media
Release Date : 2009-11-29

Acute Myelogenous Leukemia written by Judith E. Karp and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2009-11-29 with Medical categories.


This is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of acute myelogenous leukemia (AML). The focus is on selected critical molecular determinants of AML pathogenesis and pathophysiology and the exploitation of these factors by diverse therapeutic agents and modalities. There is an emphasis throughout on the bidirectional flow of knowledge between the clinical and laboratory arenas.